Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study

被引：0
|
作者：
Joaquin J. Jimenez
Tongyu C. Wikramanayake
Wilma Bergfeld
Maria Hordinsky
Janet G. Hickman
Michael R. Hamblin
Lawrence A. Schachner
机构：
[1] University of Miami Miller School of Medicine,Department of Dermatology and Cutaneous Surgery
[2] Cleveland Clinic Foundation,Department of Dermatology
[3] University of Minnesota,Department of Dermatology
[4] The Education and Research Foundation,Wellman Center for Photomedicine
[5] Inc.,Department of Dermatology
[6] Massachusetts General Hospital,undefined
[7] Harvard Medical School,undefined
[8] Harvard-MIT Division of Health Sciences and Technology,undefined
来源：
American Journal of Clinical Dermatology | 2014年 / 15卷
关键词：
Finasteride; Minoxidil; Dutasteride; Hair Density; Terminal Hair;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 127
页数：12
相关论文
共 10 条
  • [1] Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study
    Jimenez, Joaquin J.
    Wikramanayake, Tongyu C.
    Bergfeld, Wilma
    Hordinsky, Maria
    Hickman, Janet G.
    Hamblin, Michael R.
    Schachner, Lawrence A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2014, 15 (02) : 115 - 127
  • [2] HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic AlopeciaA Randomized, Double-Blind, Sham Device-Controlled, Multicentre Trial
    Matt Leavitt
    Glenn Charles
    Eugene Heyman
    David Michaels
    Clinical Drug Investigation, 2009, 29 : 283 - 292
  • [3] Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
    Eun, Hee Chul
    Kwon, Oh Sang
    Yeon, Je Ho
    Shin, Hyo Seung
    Kim, Byung Yoon
    Ro, Byung In
    Cho, Han Kyong
    Sim, Woo Young
    Lew, Bark Lynn
    Lee, Won-Soo
    Park, Hwa Young
    Hong, Seung Phil
    Ji, Jae Hong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (02) : 252 - 258
  • [4] Double-blind randomized placebo-controlled study of the efficacy and safety of hair loss prevention shampoo containing salicylic acid, panthenol, and niacinamide in alopecia patients
    Kim, Hee-Taek
    Park, Hye-Su
    Kim, Yong-Min
    Lee, In-Chul
    Lee, Sang-Jun
    Choi, Jae-Suk
    TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, 2022, 14 (02) : 173 - 185
  • [5] Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study
    Masoud, Farid
    Alamdari, Hamideh Azimi
    Asnaashari, Solmaz
    Shokri, Javad
    Javadzadeh, Yousef
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [6] Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
    Pumthong, Ganniga
    Asawanonda, Pravit
    Varothai, Supenya
    Jariyasethavong, Vorapicha
    Triwongwaranat, Daranporn
    Suthipinittharm, Puan
    Ingkaninan, Kornkanok
    Leelapornpisit, Pimporn
    Waranuch, Neti
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (05) : 385 - 392
  • [7] Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study
    Blume-Peytavi, Ulrike
    Issiakhem, Zahida
    Gautier, Stephanie
    Kottner, Jan
    Wigger-Alberti, Walter
    Fischer, Tobias
    Hoffmann, Rolf
    Tonner, Francoise
    Bouroubi, Athmane
    Voisard, Jean-Jacques
    JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (01) : 215 - 220
  • [8] Evaluation of the Efficacy and Safety of Topical Procyanidin B2 and Placebo in the Treatment of Androgenetic Alopecia in Men; A Randomized, Double-blind, Placebo-controlled Study
    Yeniay, Yildiray
    Arca, Ercan
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2022, 16 (04): : 108 - 114
  • [9] A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata
    Mirzaeei, Shahla
    Barfar, Ashkan
    Mehrandish, Saba
    Ebrahimi, Ali
    JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES, 2021, 10 (02): : 279 - 286
  • [10] A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
    Blume-Peytavi, Ulrike
    Loennfors, Sanna
    Hillmann, Kathrin
    Bartels, Natalie Garcia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : 794 - 800
1